SHS Capital, alongside its portfolio company MTR, has acquired Curatec Services GmbH to enhance its market position in electrical stimulation therapy and improve patient care in Germany.
Information on the Target
Curatec Services GmbH, based in North Rhine-Westphalia, Germany, is a leading specialist in medical electrical stimulation and rehabilitation devices. With a strong focus on neurological therapies, uro-gynaecology, and orthopaedics, Curatec has built a solid reputation over its more than 25 years of operation. The company is recognized for its high-quality medical devices, strong patient-centered service, and innovative approach to electrotherapy.
Curatec's relationships with rehabilitation clinics, hospitals, specialist practices, and homecare providers contribute to its excellent standing in the industry. It has cultivated trusted collaborations with statutory health insurers, thereby securing its status as a pioneer in the field of electrotherapy.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The healthcare sector in Germany is one of the largest and most advanced in Europe, emphasizing innovation and quality in medical technology. As a key player in healthcare, Germany is known for its robust system that combines st
Similar Deals
SHS Capital and MTR
invested in
Curatec Services GmbH
in 2025
in a Buyout deal
Disclosed details
Equity Value: $53M